California bills · 2025-2026 Regular Session
California AB 968
Contraceptives.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Boerner (Democratic)
Summary
Official abstract published by the California legislature· summary
Existing law, the Pharmacy Law, establishes, in the Department of Consumer Affairs, the California State Board of Pharmacy to license and regulate the practice of pharmacy.
Existing law authorizes a physician and surgeon, nurse practitioner, registered nurse, and specified other health care practitioners acting within the scope of their practice to use a self-screening tool to identify patient risk factors for the use of self-administered hormonal contraceptives by a patient and, after examination, to prescribe, furnish, or dispense self-administered hormonal contraceptives to the patient.
This bill would, instead, make those provisions applicable to contraceptives.
Existing law authorizes a pharmacist to furnish self-administered hormonal contraceptives in accordance with standardized procedures or protocols developed and approved by both the California State Board of Pharmacy and the Medical Board of California, in consultation with specified other entities.
This bill would authorize a pharmacist to also furnish federal Food and Drug Administration-approved nonhormonal contraceptives in accordance with those standardized procedures or protocols. The bill would require a pharmacist, for each federal Food and Drug Administration-approved nonhormonal contraceptives initiated, to provide the recipient with a standardized fact sheet, as specified.
Existing law prohibits a pharmacist, pharmacist's employer, or pharmacist's agent from directly charging a patient a separate consultation fee for emergency contraception drug therapy services and requires the pharmacist to disclose the total retail price of the emergency contraception drug therapy. Existing law makes those provisions inoperative for dedicated emergency contraception drugs if these drugs are reclassified as over-the-counter products by the federal Food and Drug Administration.
This bill would delete those provisions.
Existing law requires a pharmacist to dispense, at a patient's request, up to a 12-month supply of an FDA-approved, self-administered hormonal contraceptive.
This bill would, instead, make those provisions applicable to contraceptives.
This bill would make related conforming changes.
Text versions
- 07/09/25 - Amended Senate· Jul 9, 2025
- 06/09/25 - Amended Senate· Jun 9, 2025
- 04/07/25 - Amended Assembly· Apr 7, 2025
- 02/20/25 - Introduced· Feb 20, 2025
- AB968
Roll-call votes
State vote data last updated Oct 16, 2026, 12:24 AM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Jul 14, 2025 Senate | Do pass, but first be re-referred to the Committee on [Appropriations] | pass | Set your home in California to see |
| May 27, 2025 House | AB 968 Boerner Assembly Third Reading | pass | Set your home in California to see |
| May 21, 2025 House | Do pass. | pass | Set your home in California to see |
| Apr 29, 2025 House | Do pass and be re-referred to the Committee on [Appropriations] | pass | Set your home in California to see |
Actions
- Sep 13, 2025 · Senate
Ordered to inactive file at the request of Senator Pérez. - Aug 20, 2025 · Senate
Read second time. Ordered to third reading. - Aug 19, 2025 · Senate
From committee: Be ordered to second reading pursuant to Senate Rule 28.8. - Jul 14, 2025 · Senate
From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (July 14). Re-referred to Com. on APPR. - Jul 9, 2025 · Senate
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D. - Jul 3, 2025 · Senate
In committee: Set, first hearing. Hearing canceled at the request of author. - Jun 23, 2025 · Senate
In committee: Hearing postponed by committee. - Jun 11, 2025 · Senate
In committee: Hearing postponed by committee. - Jun 9, 2025 · Senate
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D. - Jun 4, 2025 · Senate
Referred to Com. on B. P. & E.D. - May 28, 2025 · Senate
In Senate. Read first time. To Com. on RLS. for assignment. - May 27, 2025 · House
Read third time. Passed. Ordered to the Senate. (Ayes 77. Noes 0. Page 1737.) - May 22, 2025 · House
Read second time. Ordered to third reading. - May 21, 2025 · House
From committee: Do pass. (Ayes 15. Noes 0.) (May 21). - May 14, 2025 · House
In committee: Hearing postponed by committee. - Apr 29, 2025 · House
From committee: Do pass and re-refer to Com. on APPR. (Ayes 17. Noes 0.) (April 29). Re-referred to Com. on APPR. - Apr 10, 2025 · House
Re-referred to Com. on B. & P. pursuant to Assembly Rule 96. - Apr 8, 2025 · House
Re-referred to Com. on TRANS. - Apr 7, 2025 · House
From committee chair, with author's amendments: Amend, and re-refer to Com. on TRANS. Read second time and amended. - Apr 7, 2025 · House
In committee: Set, first hearing. Hearing canceled at the request of author. - Mar 10, 2025 · House
Referred to Com. on TRANS. - Feb 21, 2025 · House
From printer. May be heard in committee March 23. - Feb 20, 2025 · House
Read first time. To print.